Cetera Advisor Networks LLC Sells 7,608 Shares of Aflac Incorporated (NYSE:AFL)

Cetera Advisor Networks LLC decreased its position in Aflac Incorporated (NYSE:AFLFree Report) by 6.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 111,243 shares of the financial services provider’s stock after selling 7,608 shares during the period. Cetera Advisor Networks LLC’s holdings in Aflac were worth $9,178,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Crossmark Global Holdings Inc. boosted its holdings in Aflac by 22.6% in the fourth quarter. Crossmark Global Holdings Inc. now owns 86,010 shares of the financial services provider’s stock valued at $7,096,000 after acquiring an additional 15,855 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in Aflac by 306.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 75,739 shares of the financial services provider’s stock valued at $6,248,000 after acquiring an additional 57,104 shares during the last quarter. Lake Street Advisors Group LLC bought a new position in Aflac during the fourth quarter worth about $325,000. Southeast Asset Advisors Inc. boosted its holdings in Aflac by 0.4% during the fourth quarter. Southeast Asset Advisors Inc. now owns 139,164 shares of the financial services provider’s stock worth $11,481,000 after buying an additional 589 shares during the last quarter. Finally, Copperwynd Financial LLC boosted its holdings in Aflac by 6.1% during the fourth quarter. Copperwynd Financial LLC now owns 3,149 shares of the financial services provider’s stock worth $260,000 after buying an additional 180 shares during the last quarter. Institutional investors own 67.44% of the company’s stock.

Aflac Stock Up 0.5 %

Shares of Aflac stock opened at $88.79 on Friday. The business’s 50 day simple moving average is $85.22 and its 200 day simple moving average is $83.16. Aflac Incorporated has a 52-week low of $66.58 and a 52-week high of $89.91. The firm has a market cap of $50.45 billion, a PE ratio of 9.80, a P/E/G ratio of 2.18 and a beta of 0.96. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.08 and a current ratio of 0.08.

Aflac (NYSE:AFLGet Free Report) last announced its earnings results on Monday, May 6th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.58 by $0.08. Aflac had a return on equity of 16.88% and a net margin of 27.67%. The business had revenue of $5.44 billion for the quarter, compared to analyst estimates of $4.09 billion. During the same quarter last year, the firm earned $1.55 EPS. Aflac’s revenue for the quarter was up 13.3% compared to the same quarter last year. On average, analysts predict that Aflac Incorporated will post 6.46 earnings per share for the current fiscal year.

Aflac Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 3rd. Shareholders of record on Wednesday, May 22nd were given a dividend of $0.50 per share. This is a positive change from Aflac’s previous quarterly dividend of $0.42. The ex-dividend date was Tuesday, May 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.25%. Aflac’s payout ratio is 22.08%.

Insiders Place Their Bets

In other Aflac news, Director Charles D. Lake II sold 22,378 shares of the business’s stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $87.47, for a total transaction of $1,957,403.66. Following the transaction, the director now owns 61,522 shares of the company’s stock, valued at approximately $5,381,329.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Aflac news, Director Charles D. Lake II sold 22,378 shares of the business’s stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $87.47, for a total transaction of $1,957,403.66. Following the transaction, the director now owns 61,522 shares of the company’s stock, valued at approximately $5,381,329.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Joseph L. Moskowitz sold 600 shares of Aflac stock in a transaction that occurred on Wednesday, May 8th. The stock was sold at an average price of $84.84, for a total value of $50,904.00. Following the transaction, the director now owns 27,550 shares of the company’s stock, valued at $2,337,342. The disclosure for this sale can be found here. Insiders have sold 35,978 shares of company stock valued at $3,098,128 in the last 90 days. 0.90% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on AFL shares. Wells Fargo & Company raised their target price on Aflac from $81.00 to $82.00 and gave the stock an “equal weight” rating in a report on Friday, May 10th. Piper Sandler raised their target price on Aflac from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Friday, April 5th. Truist Financial raised their target price on Aflac from $80.00 to $82.00 and gave the stock a “hold” rating in a report on Friday, May 3rd. Keefe, Bruyette & Woods raised their target price on Aflac from $83.00 to $87.00 and gave the stock a “market perform” rating in a report on Wednesday, April 10th. Finally, Morgan Stanley raised their price target on Aflac from $80.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Monday, April 15th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $82.38.

View Our Latest Research Report on Aflac

Aflac Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Articles

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.